November 9, 2015
Spring Bank names chief medical officer
By Sam Bonacci
Spring Bank Pharmaceuticals of Milford, has brought on Dr. Nezam Afdhal as the company’s chief medical officer, the company announced Monday.
The clinical-stage biopharmaceutical company that develops therapeutics for the treatment of viral infections has consulted with Dr. Afdhal since 2011. In his new role, he will help lead the next stage of the company’s clinical development strategy, Martin Driscoll, president and CEO of Spring Bank, said in a statement.
The company’s most advanced product candidate is a substance that could be used to fight viral infections such as HBV, HCV and RSV.
WBJ Web Partners
Most Recent
Most Recent
0 Comments